On May 15, 2020, the White House announced Operation Warp Speed to accelerate development, production, and distribution of COVID-19 vaccines, therapeutics, and diagnostics to produce and deliver 300 million doses of safe and effective vaccines with the initial doses available by January 2021.
Contributing stakeholders: Department of Defense, Department of Health and Human Services, including the Centers for Disease Control and Prevention, the U.S. Food and Drug Administration, the National Institutes of Health and the Biomedical Advanced Research and Development Authority.
OWS has five focus areas: Development and testing of vaccines; development and testing of therapeutics; development and testing of diagnostics; supply production and distribution of vaccines, diagnostics and therapeutics; security and assurance of vaccine, diagnostic and therapeutic development, testing, supply, production and distribution.